Genomic Prediction is Laboratory Services (Healthcare) in United States that focus on Basal Cell Carcinoma business. Founded in 2017. They cover business area such as developer, polygenic disease, test, IVF health outcome, patient, in vitro fertilization, chromosomal aneuploidy, screen, IVF couple, clinic, Basal Cell Carcinoma, Ovarian Cancer, Heart Attack, Inflammatory Bowel Disease, many more disorder.
Laboratory Services (Healthcare)
2017
( 7 years old in 2024 )
Basal Cell Carcinoma
-
675 US Highway One
North Brunswick, NJ 08902
United States
Private
developerpolygenic diseasetestIVF health outcomepatientin vitro fertilizationchromosomal aneuploidyscreenIVF coupleclinicBasal Cell CarcinomaOvarian CancerHeart AttackInflammatory Bowel Diseasemany more disorder
* We use standard office opening hours in near Genomic Prediction's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Genomic Prediction is Laboratory Services (Healthcare) business from United States that founded in 2017 (7 years old in 2024), Genomic Prediction business is focusing on Basal Cell Carcinoma.
Genomic Prediction headquarter office and corporate office address is located in 675 US Highway One North Brunswick, NJ 08902 United States.
Genomic Prediction was founded in United States.
In 2024, Genomic Prediction is currently focus on Basal Cell Carcinoma sector.
Above is snippet of Google Trends for "Basal Cell Carcinoma" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Genomic Prediction, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
